
ANI Pharma Reports Upbeat Q1 Earnings, Revises Full-Year Outlook: Retail’s Pleased
The CEO dismissed the impact of Trump tariffs, noting that the company produces a major portion of its goods in the U.S. Shares of ANI Pharmaceuticals, Inc. (ANIP) were in the spotlight on Friday after the company reported upbeat earnings and revised its …